Literature DB >> 1608964

Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype.

G McAllister1, A Charlesworth, C Snodin, M S Beer, A J Noble, D N Middlemiss, L L Iversen, P Whiting.   

Abstract

Degenerate primers, suitable for polymerase chain reaction studies and based on the conserved structure of G protein-coupled receptors, were used to isolate cDNA clones encoding putative G protein-coupled receptors from a human hippocampal cDNA library. One clone isolated by this approach (AC1) encoded a putative receptor with 39% amino acid sequence identity to the serotonin 5HT1A receptor and 47% identity to the 5HT1D receptor. When expressed transiently in the human embryonic kidney cell line 293, AC1 cDNA-encoded receptor displayed high affinity (Kd = 15 nM) and saturability for [3H]serotonin, suggesting that AC1 encodes a 5HT1-like receptor. However, 5-carboxamidotryptamine demonstrated low affinity (pKi = 5.15) compared with serotonin (pKi = 8.14), consistent with the observed binding of the putative 5HT1E receptor. The excellent correlation observed between the pharmacology of the expressed receptor encoded by AC1 and the human brain 5HT1E binding site confirms that AC1 encodes a 5HT1E receptor and establishes a fifth 5HT1-like receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608964      PMCID: PMC49323          DOI: 10.1073/pnas.89.12.5517

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.

Authors:  D Julius; K N Huang; T J Livelli; R Axel; T M Jessell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 2.  Subtypes of receptors for serotonin.

Authors:  A Frazer; S Maayani; B B Wolfe
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

3.  Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.

Authors:  D Julius; A B MacDermott; R Axel; T M Jessell
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

5.  An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.

Authors:  B Seed
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

7.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

8.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

9.  Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase.

Authors:  F O Levy; T Gudermann; M Birnbaumer; A J Kaumann; L Birnbaumer
Journal:  FEBS Lett       Date:  1992-01-20       Impact factor: 4.124

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  36 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

2.  Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.

Authors:  M Bühlen; K Fink; C Böing; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

4.  Molecular cloning and functional expression of a serotonin receptor from Caenorhabditis elegans.

Authors:  B Olde; W R McCombie
Journal:  J Mol Neurosci       Date:  1997-02       Impact factor: 3.444

5.  Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  L-694,247: a potent 5-HT1D receptor agonist.

Authors:  M S Beer; J A Stanton; Y Bevan; A Heald; A J Reeve; L J Street; V G Matassa; R J Hargreaves; D N Middlemiss
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.

Authors:  M G Erlander; T W Lovenberg; B M Baron; L de Lecea; P E Danielson; M Racke; A L Slone; B W Siegel; P E Foye; K Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Effects of antidepressant treatment on sexual arousal in depressed women: a preliminary FMRI study.

Authors:  Jong-Chul Yang; Jong-Il Park; Gwang-Won Kim; Sung-Jong Eun; Moo-Suk Lee; Kyung-Lae Han; Jeong-Ho Chae; Gwang-Woo Jeong
Journal:  Psychiatry Investig       Date:  2012-11-12       Impact factor: 2.505

9.  [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.

Authors:  H P Nowak; C D Mahle; F D Yocca
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  Characterization of putative 5-ht7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein.

Authors:  E Leung; L K Walsh; M T Pulido-Rios; R M Eglen
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.